Results 21 to 30 of about 2,987,019 (361)

Understanding cost-effectiveness [PDF]

Clinical Microbiology and Infection, 2010
Healthcare delivery in the USA and abroad has changed dramatically over the last several decades. Along with the growth in diagnostic and therapeutic interventions, the costs of healthcare have escalated out of proportion relative to other aspects of the economy.
Marya D. Zilberberg, Andrew F. Shorr, Andrew F. Shorr   +2 more
openaire   +3 more sources

Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?

Cost Effectiveness and Resource Allocation, 2023
Essential Emergency and Critical Care (EECC) is a novel approach to the care of critically ill patients, focusing on first-tier, effective, low-cost, life-saving care and designed to be feasible even in low-resourced and low-staffed settings.
Lorna Guinness, Angela Kairu, August Kuwawenaruwa, Karima Khalid, Khamis Awadh, Vincent Were, Edwine Barasa, Hiral Shah, Peter Baker, Carl Otto Schell, Tim Baker   +10 more
doaj   +1 more source

Cost effectiveness of treatments for wet age-related macular degeneration [PDF]

, 2011
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged >= 50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems.
Annemans, Lieven, Gallagher, Meghan, Mitchell, Paul, Thomas, Simu, White, Richard   +4 more
core   +1 more source

Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study

Cost Effectiveness and Resource Allocation, 2023
Background A health-economic evaluation related to COVID-19 is urgently needed to allocate healthcare resources efficiently; however, relevant medical cost data in Japan concerning COVID-19 are scarce.
Shunsuke Uno, Rei Goto, Kimiko Honda, Machiko Tokuda, Hirofumi Kamata, Shotaro Chubachi, Ryo Yamamoto, Yukio Sato, Koichiro Homma, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Junichi Sasaki, Koichi Fukunaga, Naoki Hasegawa   +14 more
doaj   +1 more source

Promoting cost effective prescribing [PDF]

BMJ, 1995
EDITOR,--Nick Freemantle and colleagues criticise the NHS for lagging behind Australia and Canada in promoting cost effective prescribing.1 As members of the working group that agreed the British guidance on conducting economic evaluations2 we take issue with their claim that these countries have a preferable approach.
Adrian Towse, Nicholas Wells
openaire   +3 more sources

Heterogeneity in health funding and disparities in health outcome: a comparison between high focus and non-high focus states in India

Cost Effectiveness and Resource Allocation, 2023
Background The Central Government of India introduced the National Health Mission (NHM) in 2005 to improve health outcomes by enhancing publicly financed (government) health expenditure and health infrastructure at the state level.
Ranjan Kumar Mohanty, Deepak Kumar Behera   +1 more
doaj   +1 more source

Likelihood of residential aged care use in later life: a simple approach to estimation with international comparison

Australian and New Zealand Journal of Public Health, 2015
Objectives: In New Zealand (NZ), place of death among decedents aged 65+ years has been reported as residential aged care (RAC, 38%), acute hospital (34%) or elsewhere (28%). However, lifetime risk of use of RAC (or nursing homes) is unknown.
Joanna B. Broad, Toni Ashton, Merryn Gott, Heather McLeod, Peter B. Davis, Martin J. Connolly   +5 more
doaj   +1 more source

Costs, outcomes, and cost-effectiveness of ovc interventions [PDF]

, 2010
This item is archived in the repository for materials published for the USAID supported Orphans and Vulnerable Children Comprehensive Action Research Project (OVC-CARE) at the Boston University Center for Global Health and Development.More than 1 out of ...
Larson, Bruce
core   +1 more source

Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola. [PDF]

, 2008
OBJECTIVE: To compare the cost-effectiveness of eflornithine and melarsoprol in the treatment of human African trypanosomiasis. METHOD: We used data from a Médecins Sans Frontières treatment project in Caxito, Angola to do a formal cost-effectiveness ...
Adam, Blum, Burri, Burri, Chappuis, Commission for Macroeconomics and Health, Edejer, Evans, Goldie, Legros, Louis, Lutumba, Matovu, Murray, Murray, Pepin, Pepin, Pepin, Politi, Priotto, Robays, Schmid, Schmid, Stanghellini   +23 more
core   +2 more sources

Assessing the external validity of model-based estimates of the incidence of heart attack in England: a modelling study

BMC Public Health, 2016
Background The DisMod II model is designed to estimate epidemiological parameters on diseases where measured data are incomplete and has been used to provide estimates of disease incidence for the Global Burden of Disease study.
Peter Scarborough, Kate Smolina, Anja Mizdrak, Linda Cobiac, Adam Briggs   +4 more
doaj   +1 more source